Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3745495014 | Reslizumab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3745496010 | Product containing only reslizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2842091000001115 | Reslizumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2842101000001114 | Reslizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Reslizumab | Has active ingredient | Reslizumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Reslizumab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Reslizumab | Is a | Product containing reslizumab (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Reslizumab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only reslizumab in parenteral dose form (medicinal product form) | Is a | True | Reslizumab | Inferred relationship | Existential restriction modifier | |
| Reslizumab 100mg/10ml solution for infusion vials | Is a | True | Reslizumab | Inferred relationship | Existential restriction modifier | |
| Reslizumab 25mg/2.5ml solution for infusion vials | Is a | True | Reslizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR